Oncoprotein LAMTOR5 activates GLUT1 via upregulating NF-κB in liver cancer
Accumulating reports reveal that serving as an oncogenic factor LAMTOR5 is involved in the progression of many specific cancers. Glucose transporter 1 (GLUT1) is frequently identified in many cancers. However, it remains unexplored whether GLUT1 plays a role in LAMTOR5-enhanced liver cancer. Here, w...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2019-02-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/med.2019.14.issue-1/med-2019-0022/med-2019-0022.xml?format=INT |
Summary: | Accumulating reports reveal that serving as an oncogenic factor LAMTOR5 is involved in the progression of many specific cancers. Glucose transporter 1 (GLUT1) is frequently identified in many cancers. However, it remains unexplored whether GLUT1 plays a role in LAMTOR5-enhanced liver cancer. Here, we aim to decipher the function of LAMTOR5 in the regulation of GLUT1 in liver cancer. |
---|---|
ISSN: | 2391-5463 |